semaglutide lawsuit Reports indicate that the creators of Ozempic (semaglutide) are facing a $2 billion after thousands of patients allegedly experienced severe side effects, including: Over a dozen lawsuits claim

Conclusion Gallbladder risk associated with GLP-1 therapy remains a clinically relevant but manageable consideration in 2026

Curb by Modere: A GLP-1 Boosting Weight Loss Supplement That Increases Satiety Enter Modere's Curb , a stimulant-free, flavored powder that taps into the body's natural mechanisms to help suppress appetite

Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last

Combined with the FDA inspection history (detailed below), it paints a picture that requires careful consideration

Gut probiotic Lactobacillus rhamnosus attenuates PDE4B-mediated interleukin-6 induced by SARS-CoV-2 membrane glycoprotein

I always recommend working with a qualified healthcare provider before making this decision for yourself or your children